1. Stocks
  2. Jagsonpal Pharmaceuticals Ltd.
  3. Swot
swot-logo

Jagsonpal Pharmaceuticals Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Jagsonpal Pharmaceuticals Ltd. has 14 Strengths, 7 Weaknesses, 1 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years - Nifty500

Mid-range Performer (DVM)

Company with high TTM EPS Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Companies with rising net profit margins - quarterly as well as TTM basis

Growth in Net Profit with increasing Profit Margin (QoQ)

Company with No Debt

Increasing profits every quarter for the past 3 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

Company with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Promoter decreasing their shareholding

Stocks in downtrend most likely to cross below SMA-200 soon

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Increasing Trend in Non-Core Income

RSI indicating price weakness

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Companies with improving valuation scores after share price falls

US FDA Warning Letter

Stocks with improving cash flow, with good durability

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Quarterly Net Profit with falling Profit Margin (YoY)